Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SPECIALLÆGESELSKABET HERLEV HUDKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.7% 0.7%   Bankruptcy risk   3.9% 2.1% 1.8% 4.2% 2.4% 2.3% 10.9% 10.9%   Credit score (0-100)   52 69 71 47 63 64 22 22   Credit rating   BBB A A BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.2 1.6 0.0 0.0 0.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,965 4,087 5,356 4,625 4,685 5,120 0.0 0.0   EBITDA   215 549 620 -201 1,313 300 0.0 0.0   EBIT   156 482 556 -267 1,239 231 0.0 0.0   Pre-tax profit (PTP)   147.0 479.0 553.0 -274.0 1,240.0 224.4 0.0 0.0   Net earnings   115.0 370.0 430.0 -216.0 964.0 171.8 0.0 0.0   Pre-tax profit without non-rec. items   147 479 553 -274 1,240 224 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   387 389 358 385 446 921 0.0 0.0   Shareholders equity total   418 734 1,105 825 1,721 1,768 1,334 1,334   Interest-bearing liabilities   173 7.0 29.0 9.0 10.0 9.7 0.0 0.0   Balance sheet total (assets)   799 1,243 2,405 1,278 2,182 2,490 1,334 1,334   Net Debt   171 -437 -1,379 -129 -1,327 -1,029 -1,334 -1,334     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,965 4,087 5,356 4,625 4,685 5,120 0.0 0.0   Gross profit growth   1.1% 3.1% 31.0% -13.6% 1.3% 9.3% -100.0% 0.0%   Employees   4 4 4 4 5 4 0 0   Employee growth %   -99.9% 0.0% 0.0% 0.0% 25.0% -20.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   799 1,243 2,405 1,278 2,182 2,490 1,334 1,334   Balance sheet change%   -7.1% 55.6% 93.5% -46.9% 70.7% 14.1% -46.4% 0.0%   Added value   215.0 549.0 620.0 -201.0 1,305.0 299.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   142 -65 -95 -39 -13 406 -921 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   3.9% 11.8% 10.4% -5.8% 26.4% 4.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   18.8% 47.2% 30.5% -14.5% 71.7% 9.9% 0.0% 0.0%   ROI %   25.9% 63.3% 49.8% -24.0% 92.6% 12.8% 0.0% 0.0%   ROE %   22.7% 64.2% 46.8% -22.4% 75.7% 9.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   52.3% 59.1% 45.9% 64.6% 78.9% 71.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   79.5% -79.6% -222.4% 64.2% -101.1% -343.3% 0.0% 0.0%   Gearing %   41.4% 1.0% 2.6% 1.1% 0.6% 0.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   10.4% 3.3% 16.7% 36.8% 10.5% 65.9% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.9 2.3 1.8 2.1 3.9 2.3 0.0 0.0   Current Ratio   0.9 2.3 1.8 2.1 3.9 2.3 0.0 0.0   Cash and cash equivalent   2.0 444.0 1,408.0 138.0 1,337.0 1,039.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -33.0 441.0 851.0 435.0 1,228.0 845.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   54 137 155 -50 261 75 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   54 137 155 -50 263 75 0 0   EBIT / employee   39 121 139 -67 248 58 0 0   Net earnings / employee   29 93 108 -54 193 43 0 0